Industry news in brief

This Digital Health News industry roundup features a health and social care tech entrepreneur making the King’s Birthday Honours list, nyra health’s oversubscribed seed round and a single sign-on for SystmOne and DOC@HOME. 

System C doubles its health and care user numbers
System C has seen a successful year of expansion and its technology is now being used by more than 700,000 clinicians, social workers and other health and care professionals.

The company’s technology includes electronic patient records, as well as adults’ and children’s social care systems. The 700,000+ users is almost double the number of users who were accessing the technology just four years ago.

System C has made a number of acquisitions this year already. In February it acquired Clevermed and its flagship BadgerNet solution to enhance its maternity offering. The following month it acquired Oxford Computer Consultants, an IT business specialising in integrated contracts and finance solutions for social care within local government.

With 1,000 employees, System C has achieved 80% coverage across the NHS, as well as expanding into new markets like New Zealand and Australia.

Nick Wilson, CEO of System C Healthcare, said: “We are also continuing to focus on R&D and innovation, and deliver comprehensive roadmaps closely aligned the NHS Long Term Plan and FY23 Operational Planning Guide. We continue to keep integration, improving customer experience and driving integrated pathways at the core of what we do.”

A number of contract wins and go-lives over the past year, has also bolstered the company’s growth. This has included implementing a new digital hospital pharmacy across 28 hospitals, as part of the national pharmacy project in Wales; a 10-year EPR deal with The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust, and multiple social care software contracts with local authorities.

Docobo interfaces with SystmOne for remote health monitoring data

GPs and healthcare professionals who use TPP’s SystmOne are now able to access Docobo’s DOC@HOME patient data using a single sign-on, thanks to a new interface between the two solutions.

Once logged into SystmOne, healthcare professionals will be able to view DOC@HOME patient data from within the same system. This means they’ll be able to see patients’ latest remote monitoring observations, such as temperature, blood oxygen levels, blood pressure and other recorded symptoms.

Being able to access all healthcare information from a single log-in will help support clinical decision-making about patients and provide a baseline of readings to help inform clinicians. It will also save valuable minutes for time-pressed healthcare professionals.

Dr John Parry, clinical director at TPP said: “Patient care in their own home using technology is ever increasing. I am glad to see the use of our single sign-on process, as it makes data access quicker for hard-pressed clinicians. I also look forward to further developments in the data interoperability area.”

Adrian Flowerday, managing director of Docobo added: “We are very pleased to have completed this work with TPP, this marks an important milestone for us of collaboration and interoperability.”

Health and social care tech entrepreneur awarded MBE

Peter O’Hara, founder of OLM and health and social care tech entrepreneur, has been awarded an MBE for services to social care in the King’s first Birthday Honours list.

O’Hara founded OLM in 1991 with the aim of using technology to make a positive difference to people’s lives. It now provides next generation technology in the service-as-a-software world through its flagship solutions such as the ECLIPSE platform for care; Nalytics platform for discovery; and the CareKnowledge platform for personal development.

Recognition of this kind will help to raise the profile of the social care sector and champion innovative transformation within it.

O’Hara said: “I feel deeply honoured and humbled to be named in the King’s Birthday Honours list to receive an MBE for services to social care. Such awards may appear to be individual, but they reflect the dedication and efforts of others who have shared the individual’s passion and helped them on their journey.

“I owe everything I have done and achieved to the many colleagues I have had the privilege to work with and serve over the past 33 years. This award is a recognition of our collective commitment to make a difference to all who depend on and deliver social care across the UK.”

AIVF selected as World Economic Forum’s Technology Pioneer

AIVF, a developer of AI-based solutions for IVF clinics, has been selected from hundreds of candidates by the World Economic Forum as one of its Technology Pioneers.

In total 100 Technology Pioneers were selected, all chosen for being at the forefront of new technologies and innovations and for the significant impact they can have on business and society.

Tel-Aviv based AIVF, uses artificial intelligence to optimise the IVF journey. Through its technology, it aims to help patients on a smoother, quicker and more accessible path to parenthood.

Danielle Gilboa, co-founder of AIVF, said: “We are honored to be named a Technology Pioneer by the World Economic Forum.

“AIVF is developing generative AI models that bring the most advanced computational embryology tools to maximise success rates and streamline the clinical process in the IVF lab. We are looking forward to engaging with the Forum’s Centre for Health and Healthcare, sharing our thoughts and insights with other global leaders in the field.”

As a Technology Pioneer, AIVF will work with global leaders to help address key industry and societal issues.

“We’re excited to welcome AIVF to our 2023 cohort of Technology Pioneers,” said Verena Kuhn, head of innovator communities at the World Economic Forum. “AIVF and its fellow pioneers are at the forefront of innovation and disruption of AI in healthcare. We look forward to their contribution to the forum’s content work that brings together public and private sectors to tackle these global issues.”

nyra health raises €4.5m seed round to advance digital neuro-therapy

nyra health, a digital therapy platform for neurological patients, has successfully closed a €4.5m oversubscribed seed round.

The funds will be used to help nyra health scale its presence in Germany, Austria and Switzerland (the DACH region), enhance its artificial intelligence (AI) technology and to establish a firm foundation for expanding into English-speaking markets.

Previously known as myReha, the funding announcement coincides with the company’s rebranding to nyra health.

Its flagship therapy app provides personalised therapy plans for each user and focuses on their needs in speech and cognition to aid their rehabilitation. It contains over 35,000 interactive exercises to support patients who have suffered a neurological illness such as a stroke, dementia or long covid 19.

Combining machine-learning models that analyse speech patterns with adaptive cognitive games, the app creates personal therapy training plans to build an individual’s memory, speech and attention.

The technology constructs highly detailed speech profiles. It automatically adapts each patient’s weekly plan based on individual performance and various speech biomarkers. These speech profiles also facilitate the mapping of long-term changes in dementia and other neurodegenerative diseases.

Moritz Schöllauf, co-founder and CEO of nyra health, said: “It’s fantastic to be able to scale our team and further enhance our AI-driven platform. By converging data from treatment and monitoring, we will be deeply integrated into the healthcare system and present throughout the whole patient journey for all neurological issues.”

Dexcom G6 is world’s most connected CGM

DexCom, Inc. has announced that the Dexcom G6 is the first and only continuous glucose monitoring system (CGM) to connect to the Omnipod 5 Automated Insulin Delivery (AID) System – making it the most connected CGM system in the world.

Adding another AID system to its CGM ecosystems, will help users to protect against high and low glucose levels with more choice over the automated insulin delivery system they use. The company already has collaborations with Tandem, Ypsomed and CamDiab.

Dexcom G6 was exclusively used in the clinical trials that led to the regulatory approval of Omnipod 5 in Europe and the US.

Teri Lawver, executive vice president and chief commercial officer at Dexcom, said: “Dexcom has supported more than 50 studies around the world ranging from early academic projects to increasingly sophisticated trials in collaboration with industry partners, safely powering AID systems for over 1 million patient-years of cumulative use.

“Our CGM systems were the first to enable industry-leading connectivity and we now link with over 60 connected partners worldwide.”